Endeavor

Treatment Shows Promise in Pancreatic Cancer Patients with BRCA Mutation

A study recently presented at the American Society of Clinical Oncology’s annual meeting sheds new light on pancreatic cancer’s link to the BRCA mutation and a new treatment approach specifically for

Genetic Counseling and Testing: What’s It All About?

If you or any of your relatives have had cancer, you may be wondering if the disease runs in your family.

Can a DNA Kit Predict Colorectal Cancer?

23andMe has received FDA clearance to test for genetic mutations that may increase your risk of colorectal cancer.

Are Breast Cancer Testing Guidelines Out of Date?

An estimated 10 percent of breast cancers are hereditary, making genetic testing a good tool for cancer prevention, early diagnosis and creating screening and treatment plans.

Inflammatory Breast Cancer Basics

The rare cancer is typically not diagnosed until after it has spread throughout the body.

One Target: Multiple Cancers

FDA approves new drug for adults and children with rare cancers

It’s All In Your Genes

23andMe receives FDA approval for test that could inform which drugs will work for you

Is Immunotherapy the Key to Fighting Ovarian Cancer?

Oncologists believe immunotherapy could be the missing piece of the puzzle.

Patients with Genetic Risk for Cancer Feel at Home in New Program

The GeneHome program is a hereditary clinic that sees patients who have had genetic testing and been found to carry a change in a gene that can cause cancer.